Daniel Lindholm

10.9k total citations · 1 hit paper
57 papers, 1.9k citations indexed

About

Daniel Lindholm is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Daniel Lindholm has authored 57 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 21 papers in Surgery and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Daniel Lindholm's work include Diabetes Treatment and Management (12 papers), Heart Failure Treatment and Management (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (11 papers). Daniel Lindholm is often cited by papers focused on Diabetes Treatment and Management (12 papers), Heart Failure Treatment and Management (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (11 papers). Daniel Lindholm collaborates with scholars based in Sweden, United States and United Kingdom. Daniel Lindholm's co-authors include Stefan James, Erik Ingelsson, Robert F. Storey, Anders Himmelmänn, Lars Wallentin, Philippe Gabríel Steg, Silvio E. Inzucchi, Alex Garza, Anna Maria Langkilde and Scott D. Solomon and has published in prestigious journals such as Circulation, The Journal of Cell Biology and Journal of the American College of Cardiology.

In The Last Decade

Daniel Lindholm

54 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial

2021 182 citations Scott D. Solomon, Rudolf A. de Boer et al. European Journal of Heart Failure profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Lindholm Sweden	24	734	538	350	294	199	57	1.9k
Dennis V. Cokkinos Greece	25	764 1.0×	506 0.9×	295 0.8×	416 1.4×	377 1.9×	93	1.8k
Kenta Ito Japan	27	727 1.0×	479 0.9×	129 0.4×	293 1.0×	155 0.8×	51	2.0k
Tzu‐Hsien Tsai Taiwan	25	455 0.6×	688 1.3×	124 0.4×	504 1.7×	222 1.1×	63	2.0k
Sheng‐Ying Chung Taiwan	27	468 0.6×	734 1.4×	135 0.4×	626 2.1×	400 2.0×	75	2.2k
Ciro Mauro Italy	23	953 1.3×	374 0.7×	543 1.6×	461 1.6×	137 0.7×	87	1.9k
Takanori Yasu Japan	26	975 1.3×	729 1.4×	179 0.5×	298 1.0×	358 1.8×	119	2.2k
Pasquale Mastroroberto Italy	24	1.3k 1.7×	846 1.6×	173 0.5×	183 0.6×	500 2.5×	118	2.4k
Erik Lipšic Netherlands	24	1.1k 1.5×	440 0.8×	195 0.6×	589 2.0×	188 0.9×	103	2.9k
Denis Angoulvant France	32	1.4k 1.9×	657 1.2×	129 0.4×	605 2.1×	150 0.8×	176	3.4k
Edoardo Gronda Italy	29	2.0k 2.7×	810 1.5×	166 0.5×	184 0.6×	243 1.2×	121	2.6k

Countries citing papers authored by Daniel Lindholm

Since Specialization

Citations

This map shows the geographic impact of Daniel Lindholm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Lindholm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Lindholm more than expected).

Fields of papers citing papers by Daniel Lindholm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Lindholm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Lindholm. The network helps show where Daniel Lindholm may publish in the future.

Co-authorship network of co-authors of Daniel Lindholm

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Lindholm. A scholar is included among the top collaborators of Daniel Lindholm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Lindholm. Daniel Lindholm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eriksson, Jan W., Giovanni Fanni, M. Lundqvist, et al.. (2025). SGLT2 inhibitor or metformin as standard treatment in early‐stage type 2 diabetes? Baseline data in SMARTEST , a novel, decentralised, register‐based randomised trial on prevention of diabetic complications. Diabetes Obesity and Metabolism. 28(2). 1327–1338.

Sundström, Johan, Stefan Gustafsson, Thomas Cars, & Daniel Lindholm. (2024). Heart Failure Treatment in the Last Years of Life: A Nationwide Study of 364 000 Individuals. European Journal of Heart Failure. 26(11). 2443–2450. 1 indexed citations

Bhatt, Ankeet S., Daniel Lindholm, A.A. Nilsson, et al.. (2023). Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER. American Heart Journal. 263. 133–140. 1 indexed citations

Lindholm, Daniel, Henrik Bjursten, Johan Lindbäck, et al.. (2023). Regional assessment of availability for transcatheter aortic valve implantation in Sweden: a long-term observational study. European Heart Journal - Quality of Care and Clinical Outcomes. 10(7). 641–649.

Myhre, Peder L., Muthiah Vaduganathan, Brian Claggett, et al.. (2022). Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction. JACC Heart Failure. 10(12). 902–913. 32 indexed citations

Solomon, Scott D., Rudolf A. de Boer, David L. DeMets, et al.. (2021). Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial. European Journal of Heart Failure. 23(7). 1217–1225. 182 indexed citations breakdown →

Lindholm, Daniel, Giovanna Sarno, David Erlinge, et al.. (2019). Combined association of key risk factors on ischaemic outcomes and bleeding in patients with myocardial infarction. Heart. 105(15). heartjnl–2018. 14 indexed citations

Jernberg, Tomas, Daniel Lindholm, Bodil Svennblad, et al.. (2019). Impact of ischaemic heart disease severity and age on risk of cardiovascular outcome in diabetes patients in Sweden: a nationwide observational study. BMJ Open. 9(4). e027199–e027199. 7 indexed citations

Rao, Abhiram, Daniel Lindholm, Manuel A. Rivas, et al.. (2018). Large-Scale Phenome-Wide Association Study of PCSK9 Variants Demonstrates Protection Against Ischemic Stroke. Circulation Genomic and Precision Medicine. 11(7). e002162–e002162. 45 indexed citations

10.

Lindholm, Daniel, Eri Fukaya, Nicholas J. Leeper, & Erik Ingelsson. (2018). Bioimpedance and New‐Onset Heart Failure: A Longitudinal Study of >500 000 Individuals From the General Population. Journal of the American Heart Association. 7(13). 37 indexed citations

11.

Fukaya, Eri, et al.. (2018). Clinical and genetic determinants of varicose veins : a prospective, community-based prospective study of similar to 500,000 individuals. Vascular Medicine. 23(3). 300–300. 2 indexed citations

12.

Lindholm, Daniel & Martin J. Holzmann. (2018). MACHINE LEARNING FOR IMPROVED DETECTION OF MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH CHEST PAIN IN THE EMERGENCY DEPARTMENT. Journal of the American College of Cardiology. 71(11). A225–A225. 8 indexed citations

13.

Buccheri, Sergio, Giovanna Sarno, Bo Lagerqvist, et al.. (2018). Bioabsorbable polymer everolimus-eluting stents in patients with acute myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry. EuroIntervention. 14(5). e562–e569. 5 indexed citations

14.

Johansson, Åsa, Niclas Eriksson, Daniel Lindholm, et al.. (2016). Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome. Human Molecular Genetics. 25(7). 1447–1456. 40 indexed citations

15.

Lindholm, Daniel, Robert F. Storey, Christina Christersson, et al.. (2015). Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOr. American Heart Journal. 170(3). 465–470. 9 indexed citations

16.

Lindholm, Daniel, Christoph Varenhorst, Christopher Cannon, et al.. (2014). Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial. European Heart Journal. 35(31). 2083–2093. 138 indexed citations

17.

Lindholm, Daniel, Christoph Varenhorst, Christopher P. Cannon, et al.. (2013). TICAGRELOR VERSUS CLOPIDOGREL IN PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROME: RESULTS FROM THE PLATO TRIAL. Journal of the American College of Cardiology. 61(10). E1–E1. 4 indexed citations

18.

Crona, Joakim, et al.. (2013). Effect of Temozolomide in Patients with Metastatic Bronchial Carcinoids. Neuroendocrinology. 98(2). 151–155. 61 indexed citations

19.

Johnson, Timothy D., Daniel Lindholm, & M. Denise Dowd. (2006). Child and Provider Restraints in Ambulances: Knowledge, Opinions, and Behaviors of Emergency Medical Services Providers. Academic Emergency Medicine. 13(8). 886–892. 19 indexed citations

20.

Sharma, H.S., Fred Nyberg, J. Westman, et al.. (1998). Brain derived neurotrophic factor and insulin like growth factor-1 attenuate upregulation of nitric oxide synthase and cell injury following trauma to the spinal cord. Amino Acids. 14(1-3). 121–129. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact